Hallal David

Hallal David is listed in filings as Director at Kalaris Therapeutics Inc. This profile follows SEC Form 4 activity through Jun 4, 2026, including sale activity. Recent filings connect the profile to Kalaris Therapeutics Inc (KLRS), Scholar Rock Holding Corporation (SRRK), iTeos Therapeutics, Inc. (ITOS), and Seer, Inc. (SEER). The current snapshot covers public activity from Jun 13, 2024 to Jun 4, 2026. Reported amounts are shown as $42.5K to $2.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.